GILD   $90.18  0.47% Market Closed After Close 90.0001 -0.20%

Gilead Sciences Inc
Total Cash 3.78B
totalCashPerShare 3.037
EBITDA 13.46B
Total Debt 23.35B
quickRatio 0.783
currentRatio 1.142
Total Revenue 27.80B
debtToEquity 128.318
Revenue/Share 22.298
ROA 0.11545
ROE 0.05263
grossProfits
freeCashflow 6.79B
operatingCashflow 7.47B
earningsGrowth 0.55
revenueGrowth 0.054
grossMargins 0.77443004
ebitdaMargins 0.48416
operatingMargins 0.38717
profitMargins 0.03791
enterpriseValue 130.07B
forwardPE 12.315173
floatShares 1.24B
sharesOutstanding 1.24B
sharesShort 16.48M
sharesShortPriorMonth 19.95M
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.00%
heldPercentInstitutions 0.88%
Short Ratio help_outline 2.42%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 14.672
Price To Book help_outline 6.09
earningsQuarterlyGrowth 0.55
netIncomeToCommon 1.05B
trailingEps 0.82%
forwardEps 7.25%
enterpriseToEbitda 9.66
lastDividendValue
lastDividendDate
currentQuarterEstimate 1.55 3Q 2024
institutionsCount 2327
lastUpdated Nov. 1, 2024, 6:23 p.m.